// App-Quantinova.ai

e12053 : Prognostic and predictive role of tumor-infiltrating lymphocytes in luminal b subtype breast cancer treated with neoadjuvant chemotherapy: A retrospective mono-institutional case series.

Researchers

Presenter

  • Matteo Duca

Principal Investigators

  • Biagio Paolini

  • Ester Antelmi

  • Maria Luisa Carcangiu

  • Luigi Mariani

  • Daniele Giardiello

  • Giuseppe Capri

  • Gabriella Mariani

  • Paola Mariani

  • Filippo G. De Braud

  • Giulia Valeria Bianchi

Medical Centers

  • Istituto Naz. Tumori-Fond. IRCCS- Oncologia Medica, Milan, Italy

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • Division of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • Istituto Nazionale Tumori, Milano, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 4

  • Cluster of differentiation 45

  • Cluster of differentiation 8A

  • tumor-infiltrating lymphocytes

Drug/Treatment

  • taxane

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved